Keyphrases
Autoimmune Disease
100%
COVID-19
76%
Autoimmune Phenomena
57%
Intensive Care Unit
54%
Immune Checkpoint Inhibitors
50%
Intravenous Immunoglobulin (IVIg)
50%
Cancer Patients
50%
In Cancer
50%
Intravenous Immunoglobulin Therapy
45%
Immune-related Adverse Effects
42%
Autoimmune
33%
Autoimmunity
33%
Systemic Lupus Erythematosus
31%
Intensive Care Unit Patients
31%
Adverse Events
31%
Disease Severity
30%
Ferritin Levels
29%
Sepsis Disease
29%
Sepsis
27%
Elevated Ferritin Levels
27%
Patients with COVID-19
27%
Medical Center
26%
Infection Outcome
25%
Rheumatoid Arthritis
25%
COVID-19 Pneumonia
25%
Immune Checkpoint Inhibitor Therapy
25%
Inpatient Setting
25%
Emerging Therapies
25%
Collagen-induced Arthritis
25%
Long-term Mortality
25%
Hyperferritinemic Syndrome
25%
Silicone Breast Implants
25%
Expert Insights
25%
Lupus
25%
Seasonal Influenza
25%
Cryoglobulinemia
25%
Patient Outcomes
25%
Autonomic Nervous System
25%
Inflammation
25%
Autoantibodies
25%
Bone Marrow
25%
Outlier Detection
25%
Acute Hypoxemic Respiratory Failure
25%
Screening Algorithm
25%
Maintenance Hemodialysis Patients
25%
Patient Characteristics
25%
Depression in Women
25%
Awake Extracorporeal Membrane Oxygenation
25%
Mechanical Ventilation
25%
Error Event
25%
Medicine and Dentistry
COVID-19
76%
Intensive Care Unit
59%
Diseases
53%
Systemic Lupus Erythematosus
50%
Infection
45%
Autoimmune Disease
39%
Bloodstream Infection
28%
Autoantibodies
25%
Ferritin
25%
Escherichia coli
25%
Hemodialysis
25%
Sepsis
25%
Cryoglobulinemia
25%
Immunoglobulin
25%
Malignant Neoplasm
25%
Cognitive Defect
25%
Patient Characteristics
25%
Extracorporeal Membrane Oxygenation
25%
Respiratory Failure
25%
Immune Checkpoint Inhibitor
25%
Seasonal Influenza
25%
Breast Implant
25%
Autonomic Nervous System
25%
Cephalosporin Derivative
25%
Urosepsis
25%
Sleep Disorder
25%
Histiocytic Sarcoma
25%
Receptor
25%
Artificial Respiration
22%
Comorbidity
14%
Lupus Erythematosus
14%
Acute Leukemia
12%
Macrophage
12%
Disease Course
12%
Central Nervous System
12%
Lymph Node
12%
Hematopoietic System Malignancy
12%
Neoplasm
12%
Non-Hodgkin Lymphoma
12%
Progressive Disease
12%
Dying
12%
Dysplasia
12%
Gastrointestinal Tract
12%
Adverse Effect
12%
Cancer
11%
Antibiotic Therapy
11%
Cytokine Storm
10%
Mortality Rate
9%
Side Effect
9%
B Cell
8%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
64%
Immune Checkpoint Inhibitor
50%
Sepsis
50%
Systemic Lupus Erythematosus
50%
Malignant Neoplasm
50%
Autoimmune Disease
50%
Infection
35%
Adverse Event
35%
Disease Severity
28%
Medication Error
25%
Hemodialysis
25%
Subtilisin
25%
Septic Shock
25%
Kexin
25%
Immunoglobulin
25%
Autoantibodies
25%
Receptor
25%
Serine Proteinase
25%
Sleep Disorder
25%
Cognitive Defect
25%
Bloodstream Infection
25%
Coronavirinae
25%
Mortality Rate
19%
Disease Exacerbation
16%
Side Effect
14%
Ferritin
14%
Myositis
11%
Rheumatoid Arthritis
11%
Sjoegren Syndrome
11%
Vasculitis
11%
Inflammatory Arthritis
11%
Alirocumab
10%
Comorbidity
9%
Transferase
7%
Lymphocytopenia
7%
C Reactive Protein
7%
Creatinine
7%
Lactate Dehydrogenase
7%
Alanine Aminotransferase
7%
Aspartic Acid
7%
Retrospective Study
6%
Immunotherapy
6%
Lupus Vulgaris
6%
Endothelin Receptor
5%
Adrenergic Receptor
5%
Angiotensin II
5%
Muscarinic M1 Receptor
5%
Low Density Lipoprotein
5%
Low Density Lipoprotein Receptor
5%
Memory Disorder
5%